MX2012007870A - Derivados de acido carboxilico que comprende un anillo de oxazolopirimidina 2, 5, 7-sustituido. - Google Patents
Derivados de acido carboxilico que comprende un anillo de oxazolopirimidina 2, 5, 7-sustituido.Info
- Publication number
- MX2012007870A MX2012007870A MX2012007870A MX2012007870A MX2012007870A MX 2012007870 A MX2012007870 A MX 2012007870A MX 2012007870 A MX2012007870 A MX 2012007870A MX 2012007870 A MX2012007870 A MX 2012007870A MX 2012007870 A MX2012007870 A MX 2012007870A
- Authority
- MX
- Mexico
- Prior art keywords
- carboxylic acid
- acid derivatives
- oxazolopyrimidine ring
- substituted oxazolopyrimidine
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
La presente invención se refiere a compuestos de oxazolopirimidina de la fórmula I, (Ver Formula) en la que A, R1, R2, R3, R4 y X se definen como se ha indicado en las reivindicaciones. Los compuestos de la fórmula I son adecuados, por ejemplo, para la curación de heridas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10305036 | 2010-01-13 | ||
PCT/EP2011/050298 WO2011086077A1 (de) | 2010-01-13 | 2011-01-12 | Carbonsäurederivate mit einem 2,5,7-substituierten oxazolopyrimidinring |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2012007870A true MX2012007870A (es) | 2012-07-25 |
Family
ID=42111309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012007870A MX2012007870A (es) | 2010-01-13 | 2011-01-12 | Derivados de acido carboxilico que comprende un anillo de oxazolopirimidina 2, 5, 7-sustituido. |
Country Status (21)
Country | Link |
---|---|
US (1) | US8748436B2 (es) |
EP (1) | EP2523958B1 (es) |
JP (1) | JP5844277B2 (es) |
KR (1) | KR101759117B1 (es) |
CN (1) | CN103097392B (es) |
AR (1) | AR079981A1 (es) |
AU (1) | AU2011206613B2 (es) |
BR (1) | BR112012017485A2 (es) |
CA (1) | CA2799474C (es) |
DK (1) | DK2523958T3 (es) |
ES (1) | ES2453956T3 (es) |
HK (1) | HK1180314A1 (es) |
IL (1) | IL220706A (es) |
MX (1) | MX2012007870A (es) |
MY (1) | MY156960A (es) |
PT (1) | PT2523958E (es) |
RU (1) | RU2560876C2 (es) |
SG (1) | SG182477A1 (es) |
TW (1) | TWI478929B (es) |
UY (1) | UY33177A (es) |
WO (1) | WO2011086077A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY33176A (es) | 2010-01-13 | 2011-08-31 | Sanofi Aventis | Derivados de oxazolopirimidina sustituida en 2, 5, 7. |
JP5841067B2 (ja) * | 2010-01-14 | 2016-01-06 | サノフイ | 2,5−置換されたオキサゾロピリミジン環を有するカルボン酸誘導体 |
ES2524712T3 (es) * | 2010-01-14 | 2014-12-11 | Sanofi | Derivados de oxazolopirimidina 2,5-sustituidos en calidad de agonistas de EDG-1 |
WO2011086080A1 (de) * | 2010-01-14 | 2011-07-21 | Sanofi-Aventis | Heterocyclische carbonsäurederivate mit einem 2,5-substituierten oxazolopyrimidinring |
US9321787B2 (en) | 2011-07-07 | 2016-04-26 | Sanofi | Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring |
WO2014175287A1 (ja) | 2013-04-26 | 2014-10-30 | 国立大学法人 京都大学 | 脳動脈瘤の形成および/または増大の抑制若しくは縮小用医薬組成物 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3679682A (en) * | 1970-04-23 | 1972-07-25 | Fmc Corp | CERTAIN 5H-ISOXAZOLO{8 5,4-d{9 PYRIMIDIN-4-ONES |
JP2006524672A (ja) | 2003-04-25 | 2006-11-02 | ユニバーシティー・カッレッジ・カーディフ・コンサルタンツ・リミテッド | ウイルス感染の治療において使用するための複素環式化合物 |
WO2004103309A2 (en) * | 2003-05-19 | 2004-12-02 | Irm Llc | Immunosuppressant compounds and compositions |
PE20050158A1 (es) * | 2003-05-19 | 2005-05-12 | Irm Llc | Compuestos inmunosupresores y composiciones |
US7855193B2 (en) * | 2005-11-23 | 2010-12-21 | Epix Pharmaceuticals, Inc. | S1P receptor modulating compounds and use thereof |
EP2121648A2 (en) * | 2007-03-21 | 2009-11-25 | EPIX Pharmaceuticals, Inc. | S1p receptor modulating compounds and use thereof |
TW201000099A (en) * | 2008-06-20 | 2010-01-01 | Amgen Inc | S1P1 receptor agonists and use thereof |
EP2583720A1 (en) | 2008-07-15 | 2013-04-24 | Sanofi | Oxazolopyrimidines as Edg-1 receptor agonists |
JP5841067B2 (ja) | 2010-01-14 | 2016-01-06 | サノフイ | 2,5−置換されたオキサゾロピリミジン環を有するカルボン酸誘導体 |
ES2524712T3 (es) | 2010-01-14 | 2014-12-11 | Sanofi | Derivados de oxazolopirimidina 2,5-sustituidos en calidad de agonistas de EDG-1 |
WO2011086080A1 (de) | 2010-01-14 | 2011-07-21 | Sanofi-Aventis | Heterocyclische carbonsäurederivate mit einem 2,5-substituierten oxazolopyrimidinring |
-
2011
- 2011-01-11 UY UY0001033177A patent/UY33177A/es not_active Application Discontinuation
- 2011-01-11 TW TW100100890A patent/TWI478929B/zh not_active IP Right Cessation
- 2011-01-11 AR ARP110100074A patent/AR079981A1/es unknown
- 2011-01-12 MY MYPI2012002590A patent/MY156960A/en unknown
- 2011-01-12 ES ES11700098.4T patent/ES2453956T3/es active Active
- 2011-01-12 US US13/521,827 patent/US8748436B2/en active Active
- 2011-01-12 BR BR112012017485A patent/BR112012017485A2/pt not_active IP Right Cessation
- 2011-01-12 CN CN201180013730.XA patent/CN103097392B/zh not_active Expired - Fee Related
- 2011-01-12 DK DK11700098.4T patent/DK2523958T3/da active
- 2011-01-12 RU RU2012134378/04A patent/RU2560876C2/ru not_active IP Right Cessation
- 2011-01-12 AU AU2011206613A patent/AU2011206613B2/en not_active Ceased
- 2011-01-12 WO PCT/EP2011/050298 patent/WO2011086077A1/de active Application Filing
- 2011-01-12 KR KR1020127021140A patent/KR101759117B1/ko active IP Right Grant
- 2011-01-12 PT PT117000984T patent/PT2523958E/pt unknown
- 2011-01-12 EP EP11700098.4A patent/EP2523958B1/de active Active
- 2011-01-12 MX MX2012007870A patent/MX2012007870A/es active IP Right Grant
- 2011-01-12 JP JP2012548408A patent/JP5844277B2/ja not_active Expired - Fee Related
- 2011-01-12 SG SG2012051207A patent/SG182477A1/en unknown
- 2011-01-12 CA CA2799474A patent/CA2799474C/en not_active Expired - Fee Related
-
2012
- 2012-07-01 IL IL220706A patent/IL220706A/en not_active IP Right Cessation
-
2013
- 2013-06-27 HK HK13107551.1A patent/HK1180314A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN103097392A (zh) | 2013-05-08 |
US20130079357A1 (en) | 2013-03-28 |
KR20120115397A (ko) | 2012-10-17 |
ES2453956T3 (es) | 2014-04-09 |
CN103097392B (zh) | 2015-05-13 |
CA2799474C (en) | 2018-02-20 |
TWI478929B (zh) | 2015-04-01 |
HK1180314A1 (en) | 2013-10-18 |
JP2013517239A (ja) | 2013-05-16 |
DK2523958T3 (da) | 2014-03-31 |
SG182477A1 (en) | 2012-08-30 |
PT2523958E (pt) | 2014-03-27 |
RU2560876C2 (ru) | 2015-08-20 |
IL220706A (en) | 2015-06-30 |
RU2012134378A (ru) | 2014-02-20 |
US8748436B2 (en) | 2014-06-10 |
EP2523958A1 (de) | 2012-11-21 |
CA2799474A1 (en) | 2011-07-21 |
AU2011206613B2 (en) | 2015-04-02 |
AU2011206613A1 (en) | 2012-08-02 |
EP2523958B1 (de) | 2013-12-25 |
UY33177A (es) | 2011-08-31 |
AR079981A1 (es) | 2012-03-07 |
IL220706A0 (en) | 2012-08-30 |
KR101759117B1 (ko) | 2017-07-18 |
WO2011086077A1 (de) | 2011-07-21 |
BR112012017485A2 (pt) | 2016-04-19 |
TW201136940A (en) | 2011-11-01 |
MY156960A (en) | 2016-04-15 |
JP5844277B2 (ja) | 2016-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN02751A (es) | ||
IN2014MN02574A (es) | ||
MX341133B (es) | Compuestos y metodos para la inhibición de hdac. | |
MX2014014531A (es) | Derivados de aminoquinazolina y piridopirimidina. | |
MX2012002641A (es) | Inhibidores de cinasa janus (jak). | |
IN2014MN01521A (es) | ||
MX2013000295A (es) | Procedimiento de preparacion de un inhibidor especifico de la trombina. | |
MX2012006805A (es) | Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa. | |
MX2012008141A (es) | Compuestos y metodos. | |
MX2012007341A (es) | Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso. | |
MX2012007870A (es) | Derivados de acido carboxilico que comprende un anillo de oxazolopirimidina 2, 5, 7-sustituido. | |
MX353190B (es) | Derivados de isoquinolina y naftiridina. | |
MX2012007835A (es) | Derivados de oxazolopirimidina sustituida en 2, 5,7. | |
MX2012007834A (es) | Derivados de acido carboxilico que comprenden un anillo de oxazolopirimidina 2,5-sustituido. | |
IN2015DN02424A (es) | ||
MX2012007836A (es) | Derivados de acido carboxilico heterociclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida. | |
MX2012002818A (es) | Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable. | |
MX2012007833A (es) | Derivados de acido carboxilico heterociclicos que contienen un anillo de oxazolopirimidina 2, 5, 7 - sustituido. | |
MX2012007837A (es) | Derivados de oxazolopirimidina 2, 5 - sustituidos. | |
MY164880A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
UA117849C2 (uk) | Спосіб одержання 3-заміщених складних ефірів (індол-1-іл)-оцтової кислоти | |
EP4282973A3 (en) | Processes for the preparation of pyrimidinylcyclopentane compounds | |
MY164138A (en) | Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring | |
MX2013004193A (es) | Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico. | |
MX2013009386A (es) | Nuevos compuestos de azaespirodecanona. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |